Stan Biotech Profile
Key Indicators
- Authorised Capital ₹ 1.20 Cr
as on 22-06-2024
- Paid Up Capital ₹ 6.00 M
as on 22-06-2024
- Company Age 29 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 2.22 Cr
as on 22-06-2024
- Revenue %
(FY 2020)
- Profit 86.17%
(FY 2020)
- Ebitda 95.07%
(FY 2020)
- Net Worth -0.40%
(FY 2020)
- Total Assets -2.54%
(FY 2020)
About Stan Biotech
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.20 Cr and a paid-up capital of Rs 6.00 M.
The company currently has active open charges totaling ₹2.22 Cr.
Lolakpuri Arjunrao and Lolakpuri Srikanth serve as directors at the Company.
- CIN/LLPIN
U24239TG1995PTC019340
- Company No.
019340
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
02 Feb 1995
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Stan Biotech?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Lolakpuri Arjunrao  | Managing Director | 02-Feb-1995 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Lolakpuri Srikanth | Director | 02-Feb-1995 | Current |
Financial Performance of Stan Biotech.
Stan Biotech Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 86.17% increase in profit. The company's net worth dipped by a decrease of 0.4%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Stan Biotech?
In 2020, Stan Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Sreenex Machines Private LimitedActive 28 years 10 monthsLolakpuri Arjunrao and Lolakpuri Srikanth are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of India Creation Date: 04 Mar 2004 | ₹7.40 M | Open |
State Bank Of India Creation Date: 31 May 1997 | ₹8.50 M | Open |
State Bank Of India Creation Date: 07 Nov 1994 | ₹6.30 M | Open |
How Many Employees Work at Stan Biotech?
Unlock and access historical data on people associated with Stan Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Stan Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Stan Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
